Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 17/10/18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/11/19 |
Chief Tech/Sci/R&D Officer | 51 | 23/10/18 | |
Chief Administrative Officer | - | 01/09/15 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 01/01/21 |
Nadia Agopyan
LAW | General Counsel | 62 | 15/08/19 |
General Counsel | 67 | 23/10/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 17/10/18 |
Steven Elms
BRD | Director/Board Member | 60 | 06/08/19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 08/12/21 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 17/10/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 8 919 095 | 7 830 643 ( 87,80 %) | 0 | 87,80 % |
Coordinate società
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.com![Indirizzo TapImmune Inc.(TPIV)](https://cdn.zonebourse.com/static/address/31370463.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,09% | 45,01 Mrd | |
+45,38% | 40,96 Mrd | |
-8,38% | 38,62 Mrd | |
+34,66% | 32,6 Mrd | |
-8,34% | 27,49 Mrd | |
+16,10% | 27,17 Mrd | |
+49,73% | 14,61 Mrd | |
+36,71% | 12,95 Mrd | |
-6,60% | 11,36 Mrd |